Professor Ngu studied at the University of London Medical School, in the famous St. Mary Hospital, under the tutelage of Professor Alexander Fleming who discovered Penicillin. In 1954, he was awarded the Max Bonn Prize in Pathology, when the Queen Mother of England came to recognize Professor Fleming for his work on Penicillin at the University.

Professor Ngu later specialized in Surgery, and later attended the University College Hospital in Ibadan, Nigeria, as a senior surgical registrar in 1960. Two years later, he got a Rockefeller Foundation Research Fellowship to study cancer chemotherapy at the Children's Cancer Research Foundation and Harvard Medical School in Boston, Mass. Ten years later, he received the Albert Lasker Medical Research Award in Clinical Cancer Chemotherapy.

It is his research in cancer that led him to the study of immunotherapy (getting the immune system of the body to react to cancer cells) and on to the search for a vaccine for HIV. Many cancers are caused by viruses that behave exactly like the HIV virus, in that they both elude the host defense mechanism. On October 28, 2003, Professor Ngu was awarded the Leon Sullivan Achievement Award in recognition of his work in the area of HIV/AIDS therapeutic vaccine research.

The Professor has carried out research in several domains and has published some 58 articles on general surgery, cancer and HIV/AIDS.

Anyone interested in the use of vaccine to treat HIV and eventually prevent further infections should contact:

1. Prof. Victor Anomah NGU, Tel. (237) 77 71 07 50, Send email
2. Dr. Jude Achiri Ngu, Tel:(237). 75 40 96 40, Send email
3. Dr. Henry Besong, Tel:(237) 77 40 13 56

• The scientific basis of VANHIVAX as an effective treatment and prevention of HIV/AIDS
  
  
• The conversion of HIV Sero-positive to sero-negative following VANHIVAX
  
  
• View the Updated Sero-conversion Table